Jaume Pons - Feb 3, 2022 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
President & CEO, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Feb 3, 2022
Transactions value $
$35,186
Form type
4
Date filed
2/7/2022, 07:27 AM
Previous filing
Oct 20, 2021
Next filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Options Exercise $11.8K +11.9K +2.68% $0.99* 457K Feb 3, 2022 Direct F1
transaction ALXO Common Stock Options Exercise $23.4K +12.3K +2.68% $1.91 469K Feb 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Options Exercise $0 -11.9K -4.91% $0.00 230K Feb 3, 2022 Common Stock 11.9K $0.99 Direct F2
transaction ALXO Employee Stock Option (right to buy) Options Exercise $0 -12.3K -66.66% $0.00 6.13K Feb 3, 2022 Common Stock 12.3K $1.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 226 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021.
F2 Shares subject to the option are fully vested and immediately exercisable.
F3 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.